First reported case of unexpected response to an epidermal growth factor receptor tyrosine kinase inhibitor in the I744M uncommon EGFR mutation

Emmanuelle Kempf; Ludovic Lacroix; Jean Charles Soria

doi:10.1016/j.cllc.2015.06.002

First reported case of unexpected response to an epidermal growth factor receptor tyrosine kinase inhibitor in the I744M uncommon EGFR mutation

Emmanuelle Kempf, Ludovic Lacroix, Jean Charles Soria

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

4 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	e259-e261
journal	Clinical Lung Cancer
Volume	16
Numéro de publication	6
Les DOIs	https://doi.org/10.1016/j.cllc.2015.06.002
état	Publié - 1 nov. 2015

Accès au document

10.1016/j.cllc.2015.06.002

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{97b510e3be294df2b7af563b63500bc9,

title = "First reported case of unexpected response to an epidermal growth factor receptor tyrosine kinase inhibitor in the I744M uncommon EGFR mutation",

keywords = "Gefitinib, I744M mutation, Non-small-cell lung cancer, Oncogene addiction, Rare EGFR mutation",

author = "Emmanuelle Kempf and Ludovic Lacroix and Soria, {Jean Charles}",

year = "2015",

month = nov,

day = "1",

doi = "10.1016/j.cllc.2015.06.002",

language = "English",

volume = "16",

pages = "e259--e261",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

number = "6",

}

TY - JOUR

T1 - First reported case of unexpected response to an epidermal growth factor receptor tyrosine kinase inhibitor in the I744M uncommon EGFR mutation

AU - Kempf, Emmanuelle

AU - Lacroix, Ludovic

AU - Soria, Jean Charles

PY - 2015/11/1

Y1 - 2015/11/1

KW - Gefitinib

KW - I744M mutation

KW - Non-small-cell lung cancer

KW - Oncogene addiction

KW - Rare EGFR mutation

UR - http://www.scopus.com/inward/record.url?scp=84944351942&partnerID=8YFLogxK

U2 - 10.1016/j.cllc.2015.06.002

DO - 10.1016/j.cllc.2015.06.002

M3 - Article

C2 - 26206728

AN - SCOPUS:84944351942

SN - 1525-7304

VL - 16

SP - e259-e261

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - 6

ER -